openPR Logo
Press release

Investigation for NASDAQ: VIR Investors over possible Wrongdoing at Vir Biotechnology, Inc. announced

02-27-2020 08:05 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Vir Biotechnology, Inc. (NASDAQ: VIR) shares over potential wrongdoing.

An investigation on behalf of investors in Vir Biotechnology, Inc. (NASDAQ: VIR) shares over potential wrongdoing.

An investigation was announced over potential breaches of fiduciary duties by certain directors at Vir Biotechnology, Inc.

Investors who purchased shares of Vir Biotechnology, Inc. (NASDAQ: VIR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Vir Biotechnology directors breached their fiduciary duties and caused damage to the company and its shareholders.

San Francisco, CA based Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. Vir Biotechnology, Inc. reported that its annual Total Revenue rose from $2.7 million in 2017 to 10.66 million in 2018 and that its Net Loss increased from $69.85 million in 2017 to $115.88 million in 2018.
Vir Biotechnology, Inc. went public in early October 2019 at $20.00 per share. Since then shares of Vir Biotechnology, Inc. (NASDAQ: VIR) declined to $13.39 per share on October 18, 2019.

Those who purchased shares of Vir Biotechnology, Inc. (NASDAQ: VIR) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for NASDAQ: VIR Investors over possible Wrongdoing at Vir Biotechnology, Inc. announced here

News-ID: 1948513 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Vir

SOFTWARE-DEFINED NETWORKING AND NETWORK FUTUALIZATION MARKET knowNCTION VIR indu …
“The SDN and NFV is picking up noticeable quality because of the developing mechanical progressions in systems administration and server farm union. SDN is a momentous systems administration design, which is ready to totally alter the current systems administration and server farm foundation. The SDN building structure is set to reclassify the systems administration framework to meet the developing number of system clients devouring a high data transfer capacity. With
Investigation announced for Investors in shares of Vir Biotechnology, Inc. (NASD …
Vir Biotechnology, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Vir Biotechnology, Inc. (NASDAQ: VIR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Vir Biotechnology, Inc. regarding its business, its prospects and its operations were materially false
Balancing Valves Market 2017- IMI Hydronic, Danfoss, Frese A/S, Caleffi, VIR Gro …
Apex Market Reports, recently published a detailed market research study focused on the "Balancing Valves Market" across the global, regional and country level. The report provides 360° analysis of "Balancing Valves Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Balancing Valves industry, and estimates the future trend of Balancing Valves market
Global Manual Balancing Valves Market 2017 : IMI Hydronic, Danfoss, Frese A/S, C …
QY Market Research published, Top Manufacturers Analysis Of Bidets Research Report. A market study based on the "Manual Balancing Valves Market" across the globe, recently added to the repository of Market Research, is titled ‘Global Manual Balancing Valves Market 2017’. The research report analyses the historical as well as present performance of the worldwide Manual Balancing Valves industry, and makes predictions on the future status of Manual Balancing Valves market
Global Automatic Balancing Valves Market Forecast 2017 - 2022 - IMI Hydronic , D …
According to Automatic Balancing Valves Market Report by Market.Biz: China Automatic Balancing Valves market sales revenue and India Automatic Balancing Valves market sales revenue is expected to register CAGRs of XX.XX % and XX.XX% respectively over the forecast period. Automatic Balancing Valves consumption in the ASEAN region's growth rate of XX.XX% outperforming many countries in the Europe and Americas on
Automatic Balancing Valves Market Research Report 2017: IMI Hydronic, Danfoss, F …
In this report, the global Automatic Balancing Valves market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request for sample of Automatic Balancing Valves Market research report @ https://www.qyresearchgroups.com/request-sample/365951 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate